Proposition 38 will ask voters to approve borrowing $8.4 billion to support medical research in immunology and immunotherapy.

Skyrizi and Rinvoq are growing fast, a blockbuster acquisition just closed, and the FDA handed AbbVie a fresh approval, yet ...

When researching the immune system, I sometimes encounter mysterious questions."Why does something like this happen?"The more ...

Humira, the drug that built AbbVie (NYSE:ABBV), sold $756 million last quarter, down 35.9%. And yet total revenue still ...

Kymera Therapeutics (KYMR) eyes pivotal BROADEN2 Phase 2b data for KT-621, a STAT6 degrader in atopic dermatitis—upside vs.

Basic studies led to clinical and translational advances that no one could have predicted,” Robert Gallo writes of his work ...

California voters face an unusually long list of propositions to consider on the November ballot. Here's a breakdown.

The Frontline of mRNA Vaccines, Actemra, CAR-T Cells, and Gut Immunity" by Tadamitsu Kishimoto and Akira Nakajima (Kodansha ...

While birthday candles measure the number of years someone has lived, they don't always tell the full story about someone's ...

Just shy of two months after teeing up its FcRn blocker Vyvgart Hytrulo for entry into another potential immunology niche, ...

The Austin-based microbiome testing company raised a $33M Series B, and adults now outnumber babies in its testing volume.

Eli Lilly has another promising medicine it is working on: eloralintide. It has performed well as a monotherapy in Phase 2 ...